Upexi, Inc. Price & Performance (UPXI)

Upexi, Inc. continues its pivot toward cryptocurrency, with its Quantum Hash subsidiary signing a deal to acquire a 2MW mining facility. Despite these moves, the stock remains under pressure, declining over 80% year-over-year and recently hitting a 52-week low. The company’s revenue contraction and investor caution persist.12

Upexi shareholders have approved an increase in authorized shares, potentially enabling new capital raises for acquisitions or employee compensation. At the same time, the company’s low price-to-sales ratio and shrinking revenues highlight ongoing challenges, with market sentiment remaining cautious despite recent strategic shifts.13

Both Upexi and Mangoceuticals have reported unusual trading activity following their reverse stock splits, including surges in shareholder accounts and high-frequency single-share transactions. Mangoceuticals is currently investigating these irregularities, with Upexi having previously noted similar concerns during its own split.42